SCHEMBL4288489

SCHEMBL4288489

Cn1cc(NC(=O)CCc2ccccc2)cn1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.60
HTT P42858 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.58
ALDH1A1 P00352 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
TAS2R8 Q9NYW2 1/20 0.57
LMNA P02545 1/20 0.57
WNT1 P04628 1/20 0.56
GSK3B P49841 1/20 0.56
DYRK1A Q13627 1/20 0.56
GAA P10253 3/20 0.56
NAMPT P43490 2/20 0.55
RAB9A P51151 1/20 0.53
HDAC3 O15379 2/20 0.52
HDAC8 Q9BY41 2/20 0.52
HDAC4 P56524 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC7 Q8WUI4 1/20 0.52
HDAC2 Q92769 1/20 0.52
HDAC10 Q969S8 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21533437 0.80 L3MBTL1 (0.62) MAPTHTTSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL30738415 0.79 SMN1; SMN2 (0.69) MAPTHTTSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL4288020 0.78 KMT2A (0.62) HTTSMN1; SMN2ALDH1A1L3MBTL1TAS2R8
SCHEMBL13479586 0.77 MAPT (0.64) MAPTHTTSMN1; SMN2ALDH1A1LMNA
Methyl Alcohol SCHEMBL4593446 0.77 MAPT (0.93) MAPTHTTALDH1A1L3MBTL1LMNA
SCHEMBL4285505 0.77 ALDH1A1 (0.64) MAPTHTTSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL3061430 0.77 MAPT (1.00) MAPTHTTLMNAGAARAB9A
SCHEMBL25020926 0.76 ALDH1A1 (0.73) MAPTHTTSMN1; SMN2ALDH1A1L3MBTL1
Hydrochloric Acid SCHEMBL27689202 0.75 MAPT (0.96) MAPTHTTLMNAGAARAB9A
SCHEMBL6966254 0.75 EGFR (0.70) MAPTHTTSMN1; SMN2ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090156582-A1 Pyrazole Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156582-A1 Pyrazole Compound GSK3B, GSK3A, GSKIP MAPT 868/4885HTT 4201/4885SMN1; SMN2 4064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.